We will include people with fasting blood glucose levels of less than 126 mg / dL and not suffering from any diseases. We will exclude minors, pregnant women, those planning a pregnancy, and lactating women.
Conditions
Interventions
None listed
Sponsors
KAGOME CO., LTD.
Review Team Mr. Kazutaka Yoshida, Innovation Division, KAGOME Co., Ltd. Mr. Shingo Takahashi, Innovation Division, KAGOME Co., Ltd. Ms. Ayaka Tsutsumi, Innovation Division, KAGOME Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (Study design) We will include randomized controlled trials (RCT), quasi randomized controlled trials (qRCT), non-randomized controlled trials (nonRCT) and crossover trials. We will include scientific papers. (PICO) Participant: We will include people with fasting blood glucose levels of less than 126 mg / dL and not suffering from any diseases. We will exclude minors, pregnant women, those planning a pregnancy, and lactating women. Intervention: We define oral intake of test food containing tomato-derived dietary fiber as an intervention. Comparison: We define oral intake of test food with no or low tomato-derived dietary fibers as controls. We also define maintaining daily eating habits as controls. Outcome measurement: We will evaluate postprandial blood glucose levels and AUC (areas calculated based on the change of blood glucose levels). (Language) Eligibility is not restricted by language.
Exclusion criteria
Exclusion criteria: We will exclude proceedings and unpublished studies which don't give us enough research details.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We will evaluate postprandial blood glucose levels and AUC (areas calculated based on the change of blood glucose levels). | — |
Countries
Japan
Contacts
Public ContactTakuro Inoue
KAGOME CO., LTD. Innovation Division
Outcome results
None listed